FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly orthopaedics and traumatology, namely the methods for controlling the therapeutic treatment of the patients suffering from great arthropathy. The specified effect is ensured by determining the serum cytokine level IL-1β, TNFα by the EIA method with applying diagnostic test systems before treatment, 6, 12 and 18-24 months later. If IL-1β concentration is decreased within 6-24 months, and TNFα concentration - within terms 12-24 months, conservative treatment is estimated as satisfactory. If IL-1β recovers its initial concentration within 12, 18-24, while TNFa - within 18-24, the conservative treatment is considered to be unsatisfactory.
EFFECT: estimation of stability of therapeutic treatment of great osteoarthrosis 1st stage.
4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DISEASES, ASSOCIATED WITH REDUCED BDNF PRODUCTION | 2013 |
|
RU2555344C2 |
| METHOD FOR SUPPORTING TREATMENT IN LARGE JOINT REPLACEMENT | 2012 |
|
RU2527159C2 |
| METHOD FOR IMPROVING QUALITY OF LIFE AND INCREASING PROFESSIONAL COMPETENCE IN PATIENTS WITH OSTEOARTHROSIS FULFILLING DRIVING AND SUPERVISION FUNCTIONS | 2012 |
|
RU2499595C1 |
| METHOD FOR PREDICTION OF INFECTIOUS COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2595853C1 |
| METHOD OF TREATING PROXIMAL HUMERAL INJURIES | 2013 |
|
RU2547610C1 |
| METHOD FOR IMMUNE CORRECTION IN PNEUMONIA | 2006 |
|
RU2305555C1 |
| MULTICOMPONENT VACCINE FOR IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF DISEASES CAUSED BY OPPORTUNISTIC PATHOGENS | 2022 |
|
RU2786222C1 |
| METHOD FOR TREATING EARLY KNEE OSTEOARTHROSIS | 2008 |
|
RU2367447C1 |
| METHOD OF BALNEOTHERAPY FOR PATIENTS WITH OSTEOARTHRITIS WITH CONCOMITANT HYPERTENSION | 2021 |
|
RU2817309C2 |
| METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
